|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| New Technologies to Increase Drug Candidate Survivability | ||||||||||||||||
| April 25, 2001 | ||||||||||||||||
|
Strategic Research Institute, The Doubletree Hotel - Somerset, NJ May 17-18, 2001 Sections Include: Emerging Technologies in ADME & Predictive Tox Bioanalytical Technologies Informatics w In-Silico Techniques to ADME/Tox In Vitro Screening Toxicogenomics 150 Attended 2000 Meeting! |
||||||||||||||||
| Organized by: | Glenn Pascual - Strategic Research Institute | |||||||||||||||
| Invited Speakers: | Agouron Pharmaceuticals Aventis Pharmaceuticals Bristol-Myers Squibb Dupont Pharmaceuticals Elan Pharmaceuticals Eli Lilly & Company FDA, CDER Novartis Pharma-Basel Pfizer Groton Laboratories Pfizer Global R&D Schering-Plough Research Institute Wyeth-Ayerst Research |
|||||||||||||||
| Deadline for Abstracts: | N/A | |||||||||||||||
| Registration: | 646-336-7030 or http://www.srinstitute.com/part_iter_site_page.cfm?pg=part_iter_reg_form.cfm&iteration_id=161 |
|||||||||||||||
| E-mail: | gpascual@srinstitute.com or call 212-967-0095, x245 | |||||||||||||||
| Posted by: | Glenn A. Pascual - conference organizer | |||||||||||||||
| Host: | 12.3.58.10 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||